Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients.
Baudrand R, Carvajal CA, Riquelme A, Morales M, Solis N, Pizarro M, Escalona A, Boza C, Pérez G, Domínguez A, Arrese M, Fardella CE. Baudrand R, et al. Among authors: solis n. Obes Surg. 2010 Jan;20(1):77-83. doi: 10.1007/s11695-009-9937-0. Epub 2009 Aug 19. Obes Surg. 2010. PMID: 19690925
Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients.
Nazal L, Riquelme A, Solís N, Pizarro M, Escalona A, Burotto M, Méndez JI, Saint-Jean C, Concha MJ, Giovanni S, Awruch D, Morales A, Baudrand R, Carrasco G, Domínguez MA, Padilla O, Espinoza M, Miquel JF, Nervi F, Arrese M. Nazal L, et al. Among authors: solis n. Obes Surg. 2010 Oct;20(10):1400-7. doi: 10.1007/s11695-009-0051-0. Epub 2010 Jan 12. Obes Surg. 2010. PMID: 20066503
Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
Baudrand R, Domínguez JM, Carvajal CA, Riquelme A, Campino C, Macchiavello S, Bozinovic M, Morales M, Pizarro M, Solis N, Escalona A, Boza C, Arrese M, Fardella CE. Baudrand R, et al. Among authors: solis n. Metabolism. 2011 Dec;60(12):1775-80. doi: 10.1016/j.metabol.2011.05.001. Epub 2011 Jun 24. Metabolism. 2011. PMID: 21704348
Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease.
Candia R, Riquelme A, Baudrand R, Carvajal CA, Morales M, Solís N, Pizarro M, Escalona A, Carrasco G, Boza C, Pérez G, Padilla O, Cerda J, Fardella CE, Arrese M. Candia R, et al. Among authors: solis n. Liver Int. 2012 Mar;32(3):392-9. doi: 10.1111/j.1478-3231.2011.02685.x. Epub 2011 Dec 4. Liver Int. 2012. PMID: 22136330
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
Cerda C, Pérez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, Espinoza M, Pizarro M, Solis N, Miquel JF, Arrese M. Cerda C, et al. Among authors: solis n. J Hepatol. 2007 Sep;47(3):412-7. doi: 10.1016/j.jhep.2007.04.012. Epub 2007 May 24. J Hepatol. 2007. PMID: 17560682
Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.
Espino A, Villagrán A, Vollrath V, Hanckes P, Salas R, Farah A, Solís N, Pizarro M, Escalona A, Boza C, Pérez G, Carrasco G, Padilla O, Miquel JF, Nervi F, Chavez-Tapia NC, Arab JP, Alvarez-Lobos M, Arrese M, Riquelme A. Espino A, et al. Among authors: solis n. Ann Hepatol. 2011 Oct-Dec;10(4):493-501. Ann Hepatol. 2011. PMID: 21911891 Free article.
181 results